Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it has initiated its ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and ...

A fundraising campaign has been set up for a brave 11-year-old Waterford city boy who suffers from severe epilepsy and other ...

November is National Epilepsy Awareness Month (NEAM), and the call to action is "Share Your Purple Power.” This year’s theme celebrates the unwavering strength, resilience, and courage of epilepsy ...

Korea University Guro Hospital (Hospital Director Chung Hee-jin) has been selected by the Ministry of Health and Welfare as a ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of CARVYKTI to transform outcomes in refractory multiple myeloma ...

At the age of three and a half, Dylan was diagnosed with autism, a moderate intellectual disability, drug-refractory epilepsy ...

LGS is a severe childhood form of epilepsy involving: Medication refractory seizures (when medication doesn't reduce the seizure episodes) Drop attacks (atonic seizures) Atypical absence seizures ...

Seizures are easily controlled in most of these ... Such an assumption does not necessarily mean that operation could not help in such refractory cases because, as pointed out by others ...